Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 148 articles:
HTML format
Text format



Single Articles


    January 2019
  1. BURNETT-HARTMAN AN, Hua X, Rue TC, Golchin N, et al
    Risk interval analysis of emergency room visits following colonoscopy in patients with inflammatory bowel disease.
    PLoS One. 2019;14:e0210262.
    PubMed     Text format     Abstract available


  2. HUH G, Yoon H, Choi YJ, Shin CM, et al
    Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics.
    PLoS One. 2019;14:e0210703.
    PubMed     Text format     Abstract available


  3. ROTH N, Biedermann L, Fournier N, Butter M, et al
    Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study.
    PLoS One. 2019;14:e0210436.
    PubMed     Text format     Abstract available


  4. CHIBA H, Kakuta Y, Kinouchi Y, Kawai Y, et al
    Correction: Allele-specific DNA methylation of disease susceptibility genes in Japanese patients with inflammatory bowel disease.
    PLoS One. 2019;14:e0212148.
    PubMed     Text format     Abstract available


  5. CHOI EJ, Lee HJ, Kim WJ, Han KI, et al
    Enterococcus faecalis EF-2001 protects DNBS-induced inflammatory bowel disease in mice model.
    PLoS One. 2019;14:e0210854.
    PubMed     Text format     Abstract available


  6. GONZALEZ-LOPEZ E, Kawasawa-Imamura Y, Zhang L, Huang X, et al
    A single nucleotide polymorphism in dopamine beta hydroxylase (rs6271(C>T)) is over-represented in inflammatory bowel disease patients and reduces circulating enzyme.
    PLoS One. 2019;14:e0210175.
    PubMed     Text format     Abstract available


  7. MOTOYA S, Watanabe K, Ogata H, Kanai T, et al
    Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study.
    PLoS One. 2019;14:e0212989.
    PubMed     Text format     Abstract available


  8. NISHIDA Y, Hosomi S, Yamagami H, Sugita N, et al
    Pretreatment neutrophil-to-lymphocyte ratio predicts clinical relapse of ulcerative colitis after tacrolimus induction.
    PLoS One. 2019;14:e0213505.
    PubMed     Text format     Abstract available


  9. LEE J, Jee SR, Kim HW, Baek DH, et al
    Factors associated with low adherence to oral 5-aminosalicylic acid in patients with ulcerative colitis.
    PLoS One. 2019;14:e0214129.
    PubMed     Text format     Abstract available


  10. MOTOYA S, Watanabe K, Ogata H, Kanai T, et al
    Correction: Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study.
    PLoS One. 2019;14:e0215491.
    PubMed     Text format     Abstract available


  11. REISDORF WC, Xie Q, Zeng X, Xie W, et al
    Preclinical evaluation of EPHX2 inhibition as a novel treatment for inflammatory bowel disease.
    PLoS One. 2019;14:e0215033.
    PubMed     Text format     Abstract available


  12. KALENYAK K, Heilmann RM, van de Lest CHA, Brouwers JF, et al
    Comparison of the systemic phospholipid profile in dogs diagnosed with idiopathic inflammatory bowel disease or food-responsive diarrhea before and after treatment.
    PLoS One. 2019;14:e0215435.
    PubMed     Text format     Abstract available


  13. HILLER A, Biedermann L, Fournier N, Butter M, et al
    The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort.
    PLoS One. 2019;14:e0211554.
    PubMed     Text format     Abstract available


  14. LEE JG, Han DS, Jo SV, Lee AR, et al
    Characteristics and pathogenic role of adherent-invasive Escherichia coli in inflammatory bowel disease: Potential impact on clinical outcomes.
    PLoS One. 2019;14:e0216165.
    PubMed     Text format     Abstract available


  15. HUH G, Yoon H, Choi YJ, Shin CM, et al
    Correction: Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics.
    PLoS One. 2019;14:e0216768.
    PubMed     Text format     Abstract available


  16. JANSSEN CE, Globig AM, Busse Grawitz A, Bettinger D, et al
    Seasonal variability of vitamin D status in patients with inflammatory bowel disease - A retrospective cohort study.
    PLoS One. 2019;14:e0217238.
    PubMed     Text format     Abstract available


  17. TOKSVANG LN, Schmidt MS, Arup S, Larsen RH, et al
    Hepatotoxicity during 6-thioguanine treatment in inflammatory bowel disease and childhood acute lymphoblastic leukaemia: A systematic review.
    PLoS One. 2019;14:e0212157.
    PubMed     Text format     Abstract available


  18. FRENKEL S, Bernstein CN, Sargent M, Kuang Q, et al
    Genome-wide analysis identifies rare copy number variations associated with inflammatory bowel disease.
    PLoS One. 2019;14:e0217846.
    PubMed     Text format     Abstract available


  19. SOONTARARAK S, Chow L, Johnson V, Coy J, et al
    Humoral immune responses against gut bacteria in dogs with inflammatory bowel disease.
    PLoS One. 2019;14:e0220522.
    PubMed     Text format     Abstract available


  20. RUIZ HH, Becker S, Bai Y, Cortes-Burgos LA, et al
    Pharmacological inhibition of NPY receptors illustrates dissociable features of experimental colitis in the mouse DSS model: Implications for preclinical evaluation of efficacy in an inflammatory bowel disease model.
    PLoS One. 2019;14:e0220156.
    PubMed     Text format     Abstract available


  21. WITTNER M, Schlicker V, Libera J, Bockmann JH, et al
    Comparison of the integrin alpha4beta7 expression pattern of memory T cell subsets in HIV infection and ulcerative colitis.
    PLoS One. 2019;14:e0220008.
    PubMed     Text format     Abstract available


  22. NAGANUMA M, Hirai F, Kobayashi K, Watanabe K, et al
    Middle-term prognosis in patients with ulcerative colitis who achieved clinical and endoscopic remission by budesonide rectal foam.
    PLoS One. 2019;14:e0220413.
    PubMed     Text format     Abstract available


  23. THOMAS T, Chandan JS, Li VSW, Lai CY, et al
    Global smoking trends in inflammatory bowel disease: A systematic review of inception cohorts.
    PLoS One. 2019;14:e0221961.
    PubMed     Text format     Abstract available


  24. DEURING JJ, Li M, Cao W, Chen S, et al
    Pregnane X receptor activation constrains mucosal NF-kappaB activity in active inflammatory bowel disease.
    PLoS One. 2019;14:e0221924.
    PubMed     Text format     Abstract available


    January 2018
  25. MENDALL M, Harpsoe MC, Kumar D, Andersson M, et al
    Relation of body mass index to risk of developing inflammatory bowel disease amongst women in the Danish National Birth Cohort.
    PLoS One. 2018;13:e0190600.
    PubMed     Text format     Abstract available


  26. MINTZ M, Khair S, Grewal S, LaComb JF, et al
    Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    PLoS One. 2018;13:e0190997.
    PubMed     Text format     Abstract available


  27. DE BRUYN JR, Becker MA, Steenkamer J, Wildenberg ME, et al
    Intestinal fibrosis is associated with lack of response to Infliximab therapy in Crohn's disease.
    PLoS One. 2018;13:e0190999.
    PubMed     Text format     Abstract available


  28. GARCIA-SANJUAN S, Lillo-Crespo M, Richart-Martinez M, Sanjuan-Quiles A, et al
    Healthcare professionals' views of the experiences of individuals living with Crohn's Disease in Spain. A qualitative study.
    PLoS One. 2018;13:e0190980.
    PubMed     Text format     Abstract available


  29. BALBAS-MARTINEZ V, Ruiz-Cerda L, Irurzun-Arana I, Gonzalez-Garcia I, et al
    A systems pharmacology model for inflammatory bowel disease.
    PLoS One. 2018;13:e0192949.
    PubMed     Text format     Abstract available


  30. MIJAC D, Vukovic-Petrovic I, Mijac V, Perovic V, et al
    MDR1 gene polymorphisms are associated with ulcerative colitis in a cohort of Serbian patients with inflammatory bowel disease.
    PLoS One. 2018;13:e0194536.
    PubMed     Text format     Abstract available


  31. BUHNER S, Hahne H, Hartwig K, Li Q, et al
    Protease signaling through protease activated receptor 1 mediate nerve activation by mucosal supernatants from irritable bowel syndrome but not from ulcerative colitis patients.
    PLoS One. 2018;13:e0193943.
    PubMed     Text format     Abstract available


  32. CHIBA H, Kakuta Y, Kinouchi Y, Kawai Y, et al
    Allele-specific DNA methylation of disease susceptibility genes in Japanese patients with inflammatory bowel disease.
    PLoS One. 2018;13:e0194036.
    PubMed     Text format     Abstract available


  33. KAMM F, Strauch U, Degenhardt F, Lopez R, et al
    Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease.
    PLoS One. 2018;13:e0194222.
    PubMed     Text format     Abstract available


  34. KOVACS G, Sipeki N, Suga B, Tornai T, et al
    Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients.
    PLoS One. 2018;13:e0194166.
    PubMed     Text format     Abstract available


  35. MORAN CJ, Huang H, Rivas M, Kaplan JL, et al
    Genetic variants in cellular transport do not affect mesalamine response in ulcerative colitis.
    PLoS One. 2018;13:e0192806.
    PubMed     Text format     Abstract available


  36. SAITO H, Hirayama A, Umemura T, Joshita S, et al
    Association between KIR-HLA combination and ulcerative colitis and Crohn's disease in a Japanese population.
    PLoS One. 2018;13:e0195778.
    PubMed     Text format     Abstract available


  37. WALJEE AK, Wiitala WL, Govani S, Stidham R, et al
    Correction: Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort.
    PLoS One. 2018;13:e0197341.
    PubMed     Text format     Abstract available


  38. KUTSUNA R, Tomida J, Morita Y, Kawamura Y, et al
    Paraclostridium bifermentans exacerbates pathosis in a mouse model of ulcerative colitis.
    PLoS One. 2018;13:e0197668.
    PubMed     Text format     Abstract available


  39. BOURGONJE AR, von Martels JZH, de Vos P, Faber KN, et al
    Increased fecal calprotectin levels in Crohn's disease correlate with elevated serum Th1- and Th17-associated cytokines.
    PLoS One. 2018;13:e0193202.
    PubMed     Text format     Abstract available


  40. ANAND U, Yiangou Y, Akbar A, Quick T, et al
    Glucagon-like peptide 1 receptor (GLP-1R) expression by nerve fibres in inflammatory bowel disease and functional effects in cultured neurons.
    PLoS One. 2018;13:e0198024.
    PubMed     Text format     Abstract available


  41. TIWARI V, Kedia S, Garg SK, Rampal R, et al
    CD4+ CD25+ FOXP3+ T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn's disease.
    PLoS One. 2018;13:e0193433.
    PubMed     Text format     Abstract available


  42. GRAY MA, Chao CY, Staudacher HM, Kolosky NA, et al
    Anti-TNFalpha therapy in IBD alters brain activity reflecting visceral sensory function and cognitive-affective biases.
    PLoS One. 2018;13:e0193542.
    PubMed     Text format     Abstract available


  43. STEWART DC, Berrie D, Li J, Liu X, et al
    Quantitative assessment of intestinal stiffness and associations with fibrosis in human inflammatory bowel disease.
    PLoS One. 2018;13:e0200377.
    PubMed     Text format     Abstract available


  44. YANG BR, Choi NK, Kim MS, Chun J, et al
    Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients.
    PLoS One. 2018;13:e0200363.
    PubMed     Text format     Abstract available


  45. GOVANI SM, Higgins PDR, Rubenstein JH, Stidham RW, et al
    CT utilization abruptly increases at age 18 among patients with inflammatory bowel diseases in the hospital.
    PLoS One. 2018;13:e0195022.
    PubMed     Text format     Abstract available


  46. CHEN CH, Lin CL, Jeng LB
    Association between chronic pancreatitis and urolithiasis: A population-based cohort study.
    PLoS One. 2018;13:e0194019.
    PubMed     Text format     Abstract available


  47. DECLERCQ V, Langille MGI, Van Limbergen J
    Differences in adiposity and diet quality among individuals with inflammatory bowel disease in Eastern Canada.
    PLoS One. 2018;13:e0200580.
    PubMed     Text format     Abstract available


  48. PEIRAVAN A, Bertolini F, Rothschild MF, Simpson KW, et al
    Genome-wide association studies of inflammatory bowel disease in German shepherd dogs.
    PLoS One. 2018;13:e0200685.
    PubMed     Text format     Abstract available


  49. VAN DER STAR BJ, van Dijk CE, Zock JP, Smit LAM, et al
    Healthcare utilisation prior to the diagnosis of inflammatory bowel diseases and the influence of livestock exposure: A longitudinal case-control study.
    PLoS One. 2018;13:e0195305.
    PubMed     Text format     Abstract available


  50. DE MEIJ TGJ, de Groot EFJ, Peeters CFW, de Boer NKH, et al
    Variability of core microbiota in newly diagnosed treatment-naive paediatric inflammatory bowel disease patients.
    PLoS One. 2018;13:e0197649.
    PubMed     Text format     Abstract available


  51. ARGENY S, Tamandl D, Scharitzer M, Stift A, et al
    Visceral fat area measured with computed tomography does not predict postoperative course in Crohn s disease patients.
    PLoS One. 2018;13:e0202220.
    PubMed     Text format     Abstract available


  52. LE GALL G, Kirchgesner J, Bejaoui M, Landman C, et al
    Clinical activity is an independent risk factor of ischemic heart and cerebrovascular arterial disease in patients with inflammatory bowel disease.
    PLoS One. 2018;13:e0201991.
    PubMed     Text format     Abstract available


  53. KAMM F, Strauch U, Degenhardt F, Lopez R, et al
    Correction: Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease.
    PLoS One. 2018;13:e0203709.
    PubMed     Text format     Abstract available


  54. EL-MATARY W, Deora V, Grover K
    Barriers to clinical research in children with inflammatory bowel disease: The patients' perspective.
    PLoS One. 2018;13:e0206965.
    PubMed     Text format     Abstract available


  55. ADAMS LC, Lubbe F, Bressem K, Wagner M, et al
    Non-alcoholic fatty liver disease in underweight patients with inflammatory bowel disease: A case-control study.
    PLoS One. 2018;13:e0206450.
    PubMed     Text format     Abstract available


  56. PITTET V, Vaucher C, Froehlich F, Maillard MH, et al
    Patient-reported healthcare expectations in inflammatory bowel diseases.
    PLoS One. 2018;13:e0197351.
    PubMed     Text format     Abstract available


  57. KUMAGAI J, Taida T, Ogasawara S, Nakagawa T, et al
    Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients.
    PLoS One. 2018;13:e0209352.
    PubMed     Text format     Abstract available


  58. HORN MP, Peter AM, Righini Grunder F, Leichtle AB, et al
    PR3-ANCA and panel diagnostics in pediatric inflammatory bowel disease to distinguish ulcerative colitis from Crohn's disease.
    PLoS One. 2018;13:e0208974.
    PubMed     Text format     Abstract available


  59. ABRON JD, Singh NP, Price RL, Nagarkatti M, et al
    Genistein induces macrophage polarization and systemic cytokine to ameliorate experimental colitis.
    PLoS One. 2018;13:e0199631.
    PubMed     Text format     Abstract available


  60. YILMAZ B, Spalinger MR, Biedermann L, Franc Y, et al
    The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients.
    PLoS One. 2018;13:e0199664.
    PubMed     Text format     Abstract available


  61. KAUR R, Thakur S, Rastogi P, Kaushal N, et al
    Resolution of Cox mediated inflammation by Se supplementation in mouse experimental model of colitis.
    PLoS One. 2018;13:e0201356.
    PubMed     Text format     Abstract available


  62. CAI Q, Li F, Zhou Y
    Experiences of Chinese patients with Crohn's disease in the self-administration of nasogastric feeding: A descriptive qualitative study.
    PLoS One. 2018;13:e0201421.
    PubMed     Text format     Abstract available


  63. TAJIRI H, Motoya S, Kinjo F, Maemoto A, et al
    Infliximab for pediatric patients with Crohn's disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan.
    PLoS One. 2018;13:e0201956.
    PubMed     Text format     Abstract available


  64. SZANTO K, Nyari T, Balint A, Bor R, et al
    Biological therapy and surgery rates in inflammatory bowel diseases - Data analysis of almost 1000 patients from a Hungarian tertiary IBD center.
    PLoS One. 2018;13:e0200824.
    PubMed     Text format     Abstract available


  65. LANDMAN C, Grill JP, Mallet JM, Marteau P, et al
    Inter-kingdom effect on epithelial cells of the N-Acyl homoserine lactone 3-oxo-C12:2, a major quorum-sensing molecule from gut microbiota.
    PLoS One. 2018;13:e0202587.
    PubMed     Text format     Abstract available


  66. KRUK B, Liebe R, Milkiewicz M, Wunsch E, et al
    PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC.
    PLoS One. 2018;13:e0202942.
    PubMed     Text format     Abstract available


  67. ARTHUR S, Singh S, Sundaram U
    Cyclooxygenase pathway mediates the inhibition of Na-glutamine co-transporter B0AT1 in rabbit villus cells during chronic intestinal inflammation.
    PLoS One. 2018;13:e0203552.
    PubMed     Text format     Abstract available


  68. MAHALHAL A, Williams JM, Johnson S, Ellaby N, et al
    Oral iron exacerbates colitis and influences the intestinal microbiome.
    PLoS One. 2018;13:e0202460.
    PubMed     Text format     Abstract available


  69. MATSUOKA K, Hamada S, Shimizu M, Nanki K, et al
    Factors predicting the therapeutic response to infliximab during maintenance therapy in Japanese patients with Crohn's disease.
    PLoS One. 2018;13:e0204632.
    PubMed     Text format     Abstract available


  70. ELLMANN S, Langer V, Britzen-Laurent N, Hildner K, et al
    Application of machine learning algorithms for multiparametric MRI-based evaluation of murine colitis.
    PLoS One. 2018;13:e0206576.
    PubMed     Text format     Abstract available


  71. BIELINSKI M, Lesiewska N, Bielinska J, Liebert A, et al
    Affective temperament in inflammatory bowel diseases: Another brick in the wall of differentiation.
    PLoS One. 2018;13:e0205606.
    PubMed     Text format     Abstract available


  72. SUDIRMAN S, Hsu YH, He JL, Kong ZL, et al
    Dietary polysaccharide-rich extract from Eucheuma cottonii modulates the inflammatory response and suppresses colonic injury on dextran sulfate sodium-induced colitis in mice.
    PLoS One. 2018;13:e0205252.
    PubMed     Text format     Abstract available


  73. MULLER C, Stift A, Argeny S, Bergmann M, et al
    Delta albumin is a better prognostic marker for complications following laparoscopic intestinal resection for Crohn's disease than albumin alone - A retrospective cohort study.
    PLoS One. 2018;13:e0206911.
    PubMed     Text format     Abstract available


    January 2017
  74. COSTA PEREIRA C, Duraes C, Coelho R, Gracio D, et al
    Association between Polymorphisms in Antioxidant Genes and Inflammatory Bowel Disease.
    PLoS One. 2017;12:e0169102.
    PubMed     Text format     Abstract available


  75. NISHIDA Y, Hosomi S, Yamagami H, Yukawa T, et al
    Neutrophil-to-Lymphocyte Ratio for Predicting Loss of Response to Infliximab in Ulcerative Colitis.
    PLoS One. 2017;12:e0169845.
    PubMed     Text format     Abstract available


  76. VRAKAS S, Mountzouris KC, Michalopoulos G, Karamanolis G, et al
    Intestinal Bacteria Composition and Translocation of Bacteria in Inflammatory Bowel Disease.
    PLoS One. 2017;12:e0170034.
    PubMed     Text format     Abstract available



  77. Correction: Inflammatory Bowel Disease: How Effective Is TNF-alpha Suppression?
    PLoS One. 2017;12:e0170865.
    PubMed     Text format     Abstract available


  78. SINGH H, Nugent Z, Yu BN, Lix LM, et al
    Hospital discharge abstracts have limited accuracy in identifying occurrence of Clostridium difficile infections among hospitalized individuals with inflammatory bowel disease: A population-based study.
    PLoS One. 2017;12:e0171266.
    PubMed     Text format     Abstract available


  79. KUO B, Bhasin M, Jacquart J, Scult MA, et al
    Correction: Genomic and Clinical Effects Associated with a Relaxation Response Mind-Body Intervention in Patients with Irritable Bowel Syndrome and Inflammatory Bowel Disease.
    PLoS One. 2017;12:e0172872.
    PubMed     Text format     Abstract available


  80. RANJHA R, Meena NK, Singh A, Ahuja V, et al
    Association of miR-196a-2 and miR-499 variants with ulcerative colitis and their correlation with expression of respective miRNAs.
    PLoS One. 2017;12:e0173447.
    PubMed     Text format     Abstract available


  81. LEWIS A, Felice C, Kumagai T, Lai C, et al
    The miR-200 family is increased in dysplastic lesions in ulcerative colitis patients.
    PLoS One. 2017;12:e0173664.
    PubMed     Text format     Abstract available


  82. BOR R, Farkas K, Fabian A, Balint A, et al
    Clinical role, optimal timing and frequency of serum infliximab and anti-infliximab antibody level measurements in patients with inflammatory bowel disease.
    PLoS One. 2017;12:e0172916.
    PubMed     Text format     Abstract available


  83. TOROK HP, Bellon V, Konrad A, Lacher M, et al
    Functional Toll-Like Receptor (TLR)2 polymorphisms in the susceptibility to inflammatory bowel disease.
    PLoS One. 2017;12:e0175180.
    PubMed     Text format     Abstract available


  84. NIRVANAPPA AC, Mohan CD, Rangappa S, Ananda H, et al
    Correction: Novel Synthetic Oxazines Target NF-kappaB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.
    PLoS One. 2017;12:e0175659.
    PubMed     Text format     Abstract available


  85. SULLIVAN E, Piercy J, Waller J, Black CM, et al
    Assessing gastroenterologist and patient acceptance of biosimilars in ulcerative colitis and Crohn's disease across Germany.
    PLoS One. 2017;12:e0175826.
    PubMed     Text format     Abstract available


  86. PATEL H, Lissoos T, Rubin DT
    Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States.
    PLoS One. 2017;12:e0175099.
    PubMed     Text format     Abstract available


  87. MURTHY SK, James PD, Antonova L, Chalifoux M, et al
    High end of life health care costs and hospitalization burden in inflammatory bowel disease patients: A population-based study.
    PLoS One. 2017;12:e0177211.
    PubMed     Text format     Abstract available


  88. PUGAZHENDHI S, Baskaran K, Santhanam S, Ramakrishna BS, et al
    Association of ATG16L1 gene haplotype with inflammatory bowel disease in Indians.
    PLoS One. 2017;12:e0178291.
    PubMed     Text format     Abstract available


  89. TIMMER A, Peplies J, Westphal M, Kaltz B, et al
    Transition from pediatric to adult medical care - A survey in young persons with inflammatory bowel disease.
    PLoS One. 2017;12:e0177757.
    PubMed     Text format     Abstract available


  90. SCHIEFFER KM, Bruffy SM, Rauscher R, Koltun WA, et al
    Reduced total serum bilirubin levels are associated with ulcerative colitis.
    PLoS One. 2017;12:e0179267.
    PubMed     Text format     Abstract available


  91. DE PALMA GD, Colavita I, Zambrano G, Giglio MC, et al
    Detection of colonic dysplasia in patients with ulcerative colitis using a targeted fluorescent peptide and confocal laser endomicroscopy: A pilot study.
    PLoS One. 2017;12:e0180509.
    PubMed     Text format     Abstract available


  92. CUI Y, Zhu C, Ming Z, Cao J, et al
    Molecular mechanisms by which casein glycomacropeptide maintains internal homeostasis in mice with experimental ulcerative colitis.
    PLoS One. 2017;12:e0181075.
    PubMed     Text format     Abstract available


  93. VILLORIA A, Garcia V, Dosal A, Moreno L, et al
    Fatigue in out-patients with inflammatory bowel disease: Prevalence and predictive factors.
    PLoS One. 2017;12:e0181435.
    PubMed     Text format     Abstract available


  94. VITALE S, Strisciuglio C, Pisapia L, Miele E, et al
    Cytokine production profile in intestinal mucosa of paediatric inflammatory bowel disease.
    PLoS One. 2017;12:e0182313.
    PubMed     Text format     Abstract available


  95. PITTET V, Vaucher C, Froehlich F, Burnand B, et al
    Patient self-reported concerns in inflammatory bowel diseases: A gender-specific subjective quality-of-life indicator.
    PLoS One. 2017;12:e0171864.
    PubMed     Text format     Abstract available


  96. HAMPSHIRE T, Menys A, Jaffer A, Bhatnagar G, et al
    A Probabilistic Method for Estimation of Bowel Wall Thickness in MR Colonography.
    PLoS One. 2017;12:e0168317.
    PubMed     Text format     Abstract available


  97. WILLIAMS AD, Korolkova OY, Sakwe AM, Geiger TM, et al
    Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.
    PLoS One. 2017;12:e0179710.
    PubMed     Text format     Abstract available


  98. IJAZ UZ, Quince C, Hanske L, Loman N, et al
    The distinct features of microbial 'dysbiosis' of Crohn's disease do not occur to the same extent in their unaffected, genetically-linked kindred.
    PLoS One. 2017;12:e0172605.
    PubMed     Text format     Abstract available


  99. STIDHAM RW, Wu J, Shi J, Lubman DM, et al
    Serum Glycoproteome Profiles for Distinguishing Intestinal Fibrosis from Inflammation in Crohn's Disease.
    PLoS One. 2017;12:e0170506.
    PubMed     Text format     Abstract available


  100. MICIC D, Gaetano JN, Rubin JN, Cohen RD, et al
    Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease.
    PLoS One. 2017;12:e0182900.
    PubMed     Text format     Abstract available


  101. PEREIRA SR, Pereira R, Figueiredo I, Freitas V, et al
    Comparison of anti-inflammatory activities of an anthocyanin-rich fraction from Portuguese blueberries (Vaccinium corymbosum L.) and 5-aminosalicylic acid in a TNBS-induced colitis rat model.
    PLoS One. 2017;12:e0174116.
    PubMed     Text format     Abstract available


  102. DIAS CC, Pereira Rodrigues P, Fernandes S, Portela F, et al
    The risk of disabling, surgery and reoperation in Crohn's disease - A decision tree-based approach to prognosis.
    PLoS One. 2017;12:e0172165.
    PubMed     Text format     Abstract available


  103. SABE VT, Basson AR, Jordaan E, Mazinu M, et al
    The association between environmental exposures during childhood and the subsequent development of Crohn's disease: A score analysis approach.
    PLoS One. 2017;12:e0171742.
    PubMed     Text format     Abstract available


  104. MONASTA L, Pierobon C, Princivalle A, Martelossi S, et al
    Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry.
    PLoS One. 2017;12:e0184118.
    PubMed     Text format     Abstract available


  105. SARID O, Slonim-Nevo V, Pereg A, Friger M, et al
    Coping strategies, satisfaction with life, and quality of life in Crohn's disease: A gender perspective using structural equation modeling analysis.
    PLoS One. 2017;12:e0172779.
    PubMed     Text format     Abstract available


  106. PALMIERI O, Bossa F, Valvano MR, Corritore G, et al
    Crohn's Disease Localization Displays Different Predisposing Genetic Variants.
    PLoS One. 2017;12:e0168821.
    PubMed     Text format     Abstract available


  107. OKAHARA K, Nagata N, Shimada T, Joya A, et al
    Colonic cytomegalovirus detection by mucosal PCR and antiviral therapy in ulcerative colitis.
    PLoS One. 2017;12:e0183951.
    PubMed     Text format     Abstract available


  108. RANJHA R, Meena NK, Singh A, Ahuja V, et al
    Correction: Association of miR-196a-2 and miR-499 variants with ulcerative colitis and their correlation with expression of respective miRNAs.
    PLoS One. 2017;12:e0184701.
    PubMed     Text format     Abstract available


  109. IRWIN J, Ferguson E, Simms LA, Hanigan K, et al
    A rolling phenotype in Crohn's disease.
    PLoS One. 2017;12:e0174954.
    PubMed     Text format     Abstract available


  110. MENGHINI P, Di Martino L, Lopetuso LR, Corridoni D, et al
    A novel model of colitis-associated cancer in SAMP1/YitFc mice with Crohn's disease-like ileitis.
    PLoS One. 2017;12:e0174121.
    PubMed     Text format     Abstract available


  111. SHIMADA T, Nagata N, Okahara K, Joya A, et al
    PCR detection of human herpesviruses in colonic mucosa of individuals with inflammatory bowel disease: Comparison with individuals with immunocompetency and HIV infection.
    PLoS One. 2017;12:e0184699.
    PubMed     Text format     Abstract available


  112. OH K, Oh EH, Baek S, Song EM, et al
    Elevated C-reactive protein level during clinical remission can predict poor outcomes in patients with Crohn's disease.
    PLoS One. 2017;12:e0179266.
    PubMed     Text format     Abstract available


  113. AL-JARALLAH A, Oriowo M
    The effect of sphingosine-1-phosphate on colonic smooth muscle contractility: Modulation by TNBS-induced colitis.
    PLoS One. 2017;12:e0170792.
    PubMed     Text format     Abstract available


  114. TOYONAGA T, Kobayashi T, Nakano M, Saito E, et al
    Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome.
    PLoS One. 2017;12:e0185131.
    PubMed     Text format     Abstract available


  115. KIM Y, Wu AG, Jaja-Chimedza A, Graf BL, et al
    Isothiocyanate-enriched moringa seed extract alleviates ulcerative colitis symptoms in mice.
    PLoS One. 2017;12:e0184709.
    PubMed     Text format     Abstract available


  116. BAMBA S, Sasaki M, Takaoka A, Takahashi K, et al
    Sarcopenia is a predictive factor for intestinal resection in admitted patients with Crohn's disease.
    PLoS One. 2017;12:e0180036.
    PubMed     Text format     Abstract available


  117. PENG YC, Lin CL, Sung FC
    The association between cholecystectomy and colorectal neoplasm in inflammatory bowel diseases: A population-based cohort study.
    PLoS One. 2017;12:e0177745.
    PubMed     Text format     Abstract available


  118. OH EH, Oh K, Han M, Seo H, et al
    Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factors.
    PLoS One. 2017;12:e0177479.
    PubMed     Text format     Abstract available


  119. SOMASUNDARAM R, Fernandes S, Deuring JJ, de Haar C, et al
    Analysis of SHIP1 expression and activity in Crohn's disease patients.
    PLoS One. 2017;12:e0182308.
    PubMed     Text format     Abstract available


  120. HENNENBERG EM, Eyking A, Reis H, Cario E, et al
    MDR1A deficiency restrains tumor growth in murine colitis-associated carcinogenesis.
    PLoS One. 2017;12:e0180834.
    PubMed     Text format     Abstract available


  121. ANDERSSON E, Bergemalm D, Kruse R, Neumann G, et al
    Subphenotypes of inflammatory bowel disease are characterized by specific serum protein profiles.
    PLoS One. 2017;12:e0186142.
    PubMed     Text format     Abstract available


  122. PILLAI N, Dusheiko M, Burnand B, Pittet V, et al
    A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease.
    PLoS One. 2017;12:e0185500.
    PubMed     Text format     Abstract available


  123. TAKAYASU L, Suda W, Watanabe E, Fukuda S, et al
    A 3-dimensional mathematical model of microbial proliferation that generates the characteristic cumulative relative abundance distributions in gut microbiomes.
    PLoS One. 2017;12:e0180863.
    PubMed     Text format     Abstract available


  124. HAN YM, Koh J, Kim JW, Lee C, et al
    NF-kappa B activation correlates with disease phenotype in Crohn's disease.
    PLoS One. 2017;12:e0182071.
    PubMed     Text format     Abstract available


  125. SJOBERG F, Barkman C, Nookaew I, Ostman S, et al
    Low-complexity microbiota in the duodenum of children with newly diagnosed ulcerative colitis.
    PLoS One. 2017;12:e0186178.
    PubMed     Text format     Abstract available


  126. CHEN L, Zhou Z, Yang Y, Chen N, et al
    Therapeutic effect of imiquimod on dextran sulfate sodium-induced ulcerative colitis in mice.
    PLoS One. 2017;12:e0186138.
    PubMed     Text format     Abstract available


  127. MORTENSEN JH, Manon-Jensen T, Jensen MD, Hagglund P, et al
    Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
    PLoS One. 2017;12:e0185855.
    PubMed     Text format     Abstract available


  128. PERRY T, Laffin M, Fedorak RN, Thiesen A, et al
    Ileocolic resection is associated with increased susceptibility to injury in a murine model of colitis.
    PLoS One. 2017;12:e0184660.
    PubMed     Text format     Abstract available


  129. SCALDAFERRI F, D'Ambrosio D, Holleran G, Poscia A, et al
    Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab.
    PLoS One. 2017;12:e0186575.
    PubMed     Text format     Abstract available


  130. FAGAGNINI S, Heinrich H, Rossel JB, Biedermann L, et al
    Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases.
    PLoS One. 2017;12:e0185193.
    PubMed     Text format     Abstract available


  131. FUKUDA T, Naganuma M, Sugimoto S, Nanki K, et al
    The risk factor of clinical relapse in ulcerative colitis patients with low dose 5-aminosalicylic acid as maintenance therapy: A report from the IBD registry.
    PLoS One. 2017;12:e0187737.
    PubMed     Text format     Abstract available


  132. SEKIZUKA T, Ogasawara Y, Ohkusa T, Kuroda M, et al
    Characterization of Fusobacterium varium Fv113-g1 isolated from a patient with ulcerative colitis based on complete genome sequence and transcriptome analysis.
    PLoS One. 2017;12:e0189319.
    PubMed     Text format     Abstract available


  133. LIN WC, Chang CW, Chen MJ, Chu CH, et al
    Challenges in the diagnosis of ulcerative colitis with concomitant bacterial infections and chronic infectious colitis.
    PLoS One. 2017;12:e0189377.
    PubMed     Text format     Abstract available


  134. HOLTMAN GA, Lisman-van Leeuwen Y, Kollen BJ, Norbruis OF, et al
    Diagnostic test strategies in children at increased risk of inflammatory bowel disease in primary care.
    PLoS One. 2017;12:e0189111.
    PubMed     Text format     Abstract available


  135. WILLIAMS AD, Korolkova OY, Sakwe AM, Geiger TM, et al
    Correction: Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.
    PLoS One. 2017;12:e0189551.
    PubMed     Text format     Abstract available


  136. SARGIN ZG, Erin N, Tazegul G, Elpek GO, et al
    Profound loss of neprilysin accompanied by decreased levels of neuropeptides and increased CRP in ulcerative colitis.
    PLoS One. 2017;12:e0189526.
    PubMed     Text format     Abstract available


  137. LEE JH, Kim TJ, Kim ER, Hong SN, et al
    Measurements of 6-thioguanine nucleotide levels with TPMT and NUDT15 genotyping in patients with Crohn's disease.
    PLoS One. 2017;12:e0188925.
    PubMed     Text format     Abstract available


    January 2016
  138. NIRVANAPPA AC, Mohan CD, Rangappa S, Ananda H, et al
    Novel Synthetic Oxazines Target NF-kappaB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.
    PLoS One. 2016;11:e0163209.
    PubMed     Text format     Abstract available


  139. BEN-SHACHAR S, Yanai H, Sherman Horev H, Elad H, et al
    Correction: MicroRNAs Expression in the Ileal Pouch of Patients with Ulcerative Colitis Is Robustly Up-Regulated and Correlates with Disease Phenotypes.
    PLoS One. 2016;11:e0165220.
    PubMed     Text format     Abstract available


  140. VICKERS AD, Ainsworth C, Mody R, Bergman A, et al
    Systematic Review with Network Meta-Analysis: Comparative Efficacy of Biologics in the Treatment of Moderately to Severely Active Ulcerative Colitis.
    PLoS One. 2016;11:e0165435.
    PubMed     Text format     Abstract available


  141. HSU TY, Shih HM, Wang YC, Lin LC, et al
    Effect of Alcoholic Intoxication on the Risk of Inflammatory Bowel Disease: A Nationwide Retrospective Cohort Study.
    PLoS One. 2016;11:e0165411.
    PubMed     Text format     Abstract available


  142. SUNDARRAJAN S, Arumugam M
    Comorbidities of Psoriasis - Exploring the Links by Network Approach.
    PLoS One. 2016;11:e0149175.
    PubMed     Text format     Abstract available


  143. LO WC, Arsenescu V, Arsenescu RI, Friedman A, et al
    Inflammatory Bowel Disease: How Effective Is TNF-alpha Suppression?
    PLoS One. 2016;11:e0165782.
    PubMed     Text format     Abstract available


  144. MANGUSO F, Bennato R, Lombardi G, Riccio E, et al
    Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0166455.
    PubMed     Text format     Abstract available


  145. CHIAPPONI C, Witt M, Dlugosch GE, Gulberg V, et al
    The Perception of Physician Empathy by Patients with Inflammatory Bowel Disease.
    PLoS One. 2016;11:e0167113.
    PubMed     Text format     Abstract available


  146. DONG J, Teng G, Wei T, Gao W, et al
    Methodological Quality Assessment of Meta-Analyses and Systematic Reviews of Probiotics in Inflammatory Bowel Disease and Pouchitis.
    PLoS One. 2016;11:e0168785.
    PubMed     Text format     Abstract available


  147. ZHANG F, Xu C, Ning L, Hu F, et al
    Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohn's Disease and Intestinal Tuberculosis.
    PLoS One. 2016;11:e0167109.
    PubMed     Text format     Abstract available


  148. ZEITZ J, Ak M, Muller-Mottet S, Scharl S, et al
    Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account.
    PLoS One. 2016;11:e0156666.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: